Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)

This study has been completed.
Sponsor:
Collaborators:
Johns Hopkins University Specialized Center for Cell Based Therapy
The EMMES Corporation
Information provided by (Responsible Party):
Joshua M Hare, University of Miami
ClinicalTrials.gov Identifier:
NCT00587990
First received: January 2, 2008
Last updated: July 3, 2013
Last verified: April 2013